Business Description
PharmX Technologies Ltd
NAICS : 511210
ISIN : AU0000298762
Description
PharmX Technologies Ltd Formerly Corum Group Ltd is an Australia-based software and technology company. The company has a single segment which is Health Services. In Health services, the company develops and distributes business software for the pharmacy industry with particular emphasis on point-of-sale and pharmaceutical dispensing software, support services, and associated computer hardware. It derives a majority of its revenue from the Health services business. the company discontinued the e-commerce business in 2022.
Financial Strength
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 42.9 | |||||
| Equity-to-Asset | 0.54 | |||||
| Debt-to-Equity | 0.02 | |||||
| Debt-to-EBITDA | 0.4 | |||||
| Piotroski F-Score | 4/9 | |||||
| Altman Z-Score | -1.7 | |||||
| Beneish M-Score | -4.26 | |||||
| WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | -26.3 | |||||
| 3-Year Book Growth Rate | 6.1 |
Momentum Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 15.61 | |||||
| 9-Day RSI | 31.33 | |||||
| 14-Day RSI | 40.53 | |||||
| 6-1 Month Momentum % | -33.33 | |||||
| 12-1 Month Momentum % | -30.23 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 1.37 | |||||
| Quick Ratio | 1.37 | |||||
| Cash Ratio | 1.08 | |||||
| Days Inventory | 9.95 | |||||
| Days Sales Outstanding | 194.03 | |||||
| Days Payable | 707.21 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Dividend Yield % | 25 | |||||
| Forward Dividend Yield % | 25 | |||||
| 5-Year Yield-on-Cost % | 25 | |||||
| 3-Year Average Share Buyback Ratio | -12.1 | |||||
| Shareholder Yield % | 48.87 |
Profitability Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 67.19 | |||||
| Operating Margin % | -9.72 | |||||
| Net Margin % | -71.94 | |||||
| FCF Margin % | 285.27 | |||||
| ROE % | -10.89 | |||||
| ROA % | -6.95 | |||||
| ROIC % | 0.79 | |||||
| ROC (Joel Greenblatt) % | 63.93 | |||||
| ROCE % | 0.7 | |||||
| Years of Profitability over Past 10-Year | 7 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PS Ratio | 6 | |||||
| PB Ratio | 1.11 | |||||
| Price-to-Tangible-Book | 3 | |||||
| Price-to-Free-Cash-Flow | 2.14 | |||||
| Price-to-Operating-Cash-Flow | 1.66 | |||||
| EV-to-EBIT | 37.21 | |||||
| EV-to-EBITDA | 7.9 | |||||
| EV-to-Revenue | 1.89 | |||||
| EV-to-FCF | 0.73 | |||||
| Price-to-Projected-FCF | 1.5 | |||||
| Price-to-Median-PS-Value | 1.5 | |||||
| Price-to-Net-Current-Asset-Value | 3 | |||||
| Earnings Yield (Greenblatt) % | 2.69 | |||||
| FCF Yield % | 48.86 | |||||
| Forward Rate of Return (Yacktman) % | -0.18 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
PharmX Technologies Ltd Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil A$) | 3.075 | ||
| EPS (TTM) (A$) | -0.004 | ||
| Beta | 0.58 | ||
| Volatility % | 48.87 | ||
| 14-Day RSI | 40.53 | ||
| 14-Day ATR (A$) | 0.000715 | ||
| 20-Day SMA (A$) | 0.03145 | ||
| 12-1 Month Momentum % | -30.23 | ||
| 52-Week Range (A$) | 0.012 - 0.053 | ||
| Shares Outstanding (Mil) | 598.51 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 4 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
PharmX Technologies Ltd Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
PharmX Technologies Ltd Stock Events
| Event | Date | Price(A$) | ||
|---|---|---|---|---|
| No Event Data | ||||
PharmX Technologies Ltd Frequently Asked Questions
What is PharmX Technologies Ltd(ASX:PHX)'s stock price today?
The current price of ASX:PHX is A$0.03. The 52 week high of ASX:PHX is A$0.05 and 52 week low is A$0.01.
When is next earnings date of PharmX Technologies Ltd(ASX:PHX)?
The next earnings date of PharmX Technologies Ltd(ASX:PHX) is .
Does PharmX Technologies Ltd(ASX:PHX) pay dividends? If so, how much?
The Dividend Yield %  of PharmX Technologies Ltd(ASX:PHX) is 25% (As of Today), Highest Dividend Payout Ratio of PharmX Technologies Ltd(ASX:PHX) was 0.73. The lowest was 0.63. And the median was 0.68. The  Forward Dividend Yield % of PharmX Technologies Ltd(ASX:PHX) is 25%. For more information regarding to dividend, please check our Dividend Page.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers